<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd"><id>2943862</id><setSpec>journal_article</setSpec><setSpec>doc-type:article</setSpec><setSpec>ddc:610</setSpec><setSpec>journal_articleFtxt</setSpec><setSpec>open_access</setSpec>

<genre>article</genre>

<titleInfo><title>The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial</title></titleInfo>

  
  
<titleInfo type="alternative">
  
  <title>TB and Tobacco trial</title>
</titleInfo>

<note type="publicationStatus">published</note>



<name type="personal">
  <namePart type="given">Omara</namePart>
  <namePart type="family">Dogar</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Deepa</namePart>
  <namePart type="family">Barua</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Melanie</namePart>
  <namePart type="family">Böckmann</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">165672182</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0001-5909-5508</description></name>
<name type="personal">
  <namePart type="given">Helen</namePart>
  <namePart type="family">Elsey</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Razia</namePart>
  <namePart type="family">Fatima</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Rhian</namePart>
  <namePart type="family">Gabe</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Rumana</namePart>
  <namePart type="family">Huque</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Ada</namePart>
  <namePart type="family">Keding</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Amina</namePart>
  <namePart type="family">Khan</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Daniel</namePart>
  <namePart type="family">Kotz</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Eva</namePart>
  <namePart type="family">Kralikova</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">James N.</namePart>
  <namePart type="family">Newell</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Iveta</namePart>
  <namePart type="family">Nohavova</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Steve</namePart>
  <namePart type="family">Parrott</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Anne</namePart>
  <namePart type="family">Readshaw</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Lottie</namePart>
  <namePart type="family">Renwick</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Aziz</namePart>
  <namePart type="family">Sheikh</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Kamran</namePart>
  <namePart type="family">Siddiqi</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>







<name type="corporate">
  <namePart/>
  <identifier type="local">175761</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>









<relatedItem type="constituent">
  <location>
    <url displayLabel="add.14242.pdf">https://pub.uni-bielefeld.de/download/2943862/2955710/add.14242.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription>
  <accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem>
<originInfo><publisher>Wiley</publisher><dateIssued encoding="w3cdtf">2018</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>



<relatedItem type="host"><titleInfo><title>Addiction</title></titleInfo>
  <identifier type="issn">0965-2140</identifier>
  <identifier type="MEDLINE">29676824</identifier>
  <identifier type="ISI">000440644200016</identifier><identifier type="urn">urn:nbn:de:0070-pub-29438621</identifier><identifier type="doi">10.1111/add.14242</identifier>
<part><detail type="volume"><number>113</number></detail><detail type="issue"><number>9</number></detail><extent unit="pages">1716-1726</extent>
</part>
</relatedItem>

<note type="extern">yes</note>
<extension>
<bibliographicCitation>
<wels>Dogar, O.; Barua, D.; Böckmann, M.; Elsey, H.; Fatima, R.; Gabe, R.; Huque, R.; Keding, A.; Khan, A.; Kotz, D.; Kralikova, E.; Newell, J. N.; Nohavova, I.; Parrott, S.; Readshaw, A.; Renwick, L.; Sheikh, A.; Siddiqi, K. (2018): The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial &lt;em&gt;Addiction&lt;/em&gt;,113:(9): 1716-1726.</wels>
<harvard1>Dogar, O., et al., 2018. The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. &lt;em&gt;Addiction&lt;/em&gt;, 113(9), p 1716-1726.</harvard1>
<bio1>Dogar O, Barua D, Böckmann M, Elsey H, Fatima R, Gabe R, Huque R, Keding A, Khan A, Kotz D, Kralikova E, Newell JN, Nohavova I, Parrott S, Readshaw A, Renwick L, Sheikh A, Siddiqi K (2018) &lt;br /&gt;The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial.&lt;br /&gt;Addiction 113(9): 1716-1726.</bio1>
<apa_indent>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., et al. (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. &lt;em&gt;Addiction&lt;/em&gt;, &lt;em&gt;113&lt;/em&gt;(9), 1716-1726. &lt;a href="https://doi.org/10.1111/add.14242" target="_blank"&gt;https://doi.org/10.1111/add.14242&lt;/a&gt;&lt;/div&gt;</apa_indent>
<angewandte-chemie>O.  Dogar, D.  Barua, M.  Böckmann, H.  Elsey, R.  Fatima, R.  Gabe, R.  Huque, A.  Keding, A.  Khan, D.  Kotz, et al., “The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial”, &lt;em&gt;Addiction&lt;/em&gt;, &lt;strong&gt;2018&lt;/strong&gt;, &lt;em&gt;113&lt;/em&gt;, 1716-1726.</angewandte-chemie>
<ama>Dogar O, Barua D, Böckmann M, et al. The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. &lt;em&gt;Addiction&lt;/em&gt;. 2018;113(9):1716-1726.</ama>
<frontiers>Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., et al. (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. &lt;em&gt;Addiction&lt;/em&gt; 113, 1716-1726.</frontiers>
<dgps>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., Kralikova, E., Newell, J.N., Nohavova, I., Parrott, S., Readshaw, A., Renwick, L., Sheikh, A. &amp;amp; Siddiqi, K. (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. &lt;em&gt;Addiction&lt;/em&gt;, &lt;em&gt;113&lt;/em&gt;(9), 1716-1726. Wiley. doi:10.1111/add.14242.&lt;/div&gt;</dgps>
<apa>Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., et al. (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. &lt;em&gt;Addiction&lt;/em&gt;, &lt;em&gt;113&lt;/em&gt;(9), 1716-1726. &lt;a href="https://doi.org/10.1111/add.14242" target="_blank"&gt;https://doi.org/10.1111/add.14242&lt;/a&gt;</apa>
<ieee> O. Dogar, et al., “The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial”, &lt;em&gt;Addiction&lt;/em&gt;,  vol. 113, 2018,  pp. 1716-1726.</ieee>
<lncs> Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., Kralikova, E., Newell, J.N., Nohavova, I., Parrott, S., Readshaw, A., Renwick, L., Sheikh, A., Siddiqi, K.: The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction. 113, 1716-1726 (2018).</lncs>
<chicago>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Dogar, Omara, Barua, Deepa, Böckmann, Melanie, Elsey, Helen, Fatima, Razia, Gabe, Rhian, Huque, Rumana, et al. 2018. “The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial”. &lt;em&gt;Addiction&lt;/em&gt; 113 (9): 1716-1726.&lt;/div&gt;</chicago>
<mla>Dogar, Omara, Barua, Deepa, Böckmann, Melanie, Elsey, Helen, Fatima, Razia, Gabe, Rhian, Huque, Rumana, Keding, Ada, Khan, Amina, Kotz, Daniel, Kralikova, Eva, Newell, James N., Nohavova, Iveta, Parrott, Steve, Readshaw, Anne, Renwick, Lottie, Sheikh, Aziz, and Siddiqi, Kamran. “The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial”. &lt;em&gt;Addiction&lt;/em&gt; 113.9 (2018): 1716-1726.</mla>
<default>Dogar O, Barua D, Böckmann M, Elsey H, Fatima R, Gabe R, Huque R, Keding A, Khan A, Kotz D, Kralikova E, et al. (2018) &lt;br /&gt;&lt;em&gt;Addiction&lt;/em&gt; 113(9): 1716-1726.</default>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>2943862</recordIdentifier><recordCreationDate encoding="w3cdtf">2020-06-12T06:57:09Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2021-06-22T05:44:45Z</recordChangeDate>
</recordInfo>
</mods>